Ovarian cancer risk study: specimens and health data
Part of Cancer, Genetic & congenital, Hormones & metabolism, Skin, Women’s health & pregnancy clinical trials.
This study collects tissue samples and medical information from people at higher risk for ovarian cancer or undergoing gynecologic surgery. Researchers use this data to develop better ways to detect and prevent ovarian cancer early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–80
- Either at increased risk for ovarian cancer (due to family history, genetic factors, or genetic counselor assessment) OR scheduled for gynecologic surgery
- Willing to provide tissue samples and medical information
- Family history of ovarian, fallopian tube, peritoneal, or pancreatic cancer, OR personal/family history of hereditary cancer syndrome, OR undergoing gynecologic surgery for any reason
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows women who carry gene mutations that increase ovarian cancer risk to understand how preventive surgery affects their health, quality of life, and peace of mind. Researchers will track your outcomes over 3 years to help inform future treatment decisions for others at similar risk.
This study collects blood (and possibly tumor tissue) to learn how certain inherited gene changes relate to breast and ovarian cancer risk. It may help researchers understand which people are most likely to develop these cancers and how tumors differ in high-risk patients.
This study looks at how well a blood test called CA-125, along with other markers and checkups, can detect ovarian cancer early. It’s for women considered low risk who will do regular blood tests and possibly a vaginal ultrasound if results suggest it.
This study aims to improve care for ovarian cancer by including people at different stages: those being checked for it, those with known risk factors, and those who are generally healthy. It could help researchers better understand and support patients and their families.
This study tests genetic (DNA) information to help doctors identify ovarian or uterine (endometrial) cancer sooner. You may be asked to do this around the time of planned surgery, when tissue is removed and can be checked for genetic clues.
This study uses lab testing to create a “map” of ovarian cancer cells one cell at a time, to better understand the disease. It likely helps researchers learn which cell types are involved, using samples collected around your surgery.
Hear when a new Cervical Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.